RAPT Therapeutics, Inc. - COM (RAPT)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
15.7 M
Holdings value Q1 2024
$141 M
Value change Q1 2024
-$170 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
56
Number of buys Q1 2024
33
Number of sells Q1 2024
-40
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
75382E109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 15.7 M $141 M -$170 M $8.98 56
2023 Q4 33.9 M $843 M -$307 K $24.85 110
2023 Q3 34.8 M $578 M +$6.72 M $16.62 98
2023 Q2 34.1 M $637 M +$14.4 M $18.70 98
2023 Q1 33.3 M $611 M +$19.8 M $18.35 104
2022 Q4 32.1 M $635 M +$67.4 M $19.80 92
2022 Q3 29.2 M $702 M -$15.8 M $24.06 91
2022 Q2 28.7 M $523 M +$30.2 M $18.25 83
2022 Q1 28 M $615 M -$10.2 M $21.99 79
2021 Q4 27.7 M $1.02 B +$58.6 M $36.73 99
2021 Q3 24.9 M $774 M -$11.9 M $31.05 106
2021 Q2 25.3 M $804 M +$200 M $31.79 109
2021 Q1 21.1 M $468 M +$14.6 M $22.20 80
2020 Q4 19.7 M $389 M -$1.78 M $19.75 80
2020 Q3 16.8 M $542 M +$65.3 M $32.20 66
2020 Q2 14.8 M $430 M +$93.9 M $29.02 52
2020 Q1 11.7 M $248 M +$53.9 M $21.27 35
2019 Q4 9.14 M $252 M +$252 M $27.61 26